Zealand pays $30 million upfront for AI-designed protein drugs across two programs, after a rough year for its amylin candidate petrelintide and its stock.
Recap by typeshit. Full story at Independent Journal Review.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
A short clip from obesity doctor Nadolsky with his three pointers for people about to begin GLP-1 treatment. The details are in the video.
A quick list of foods like eggs, Greek yogurt, salmon, lentils and oats, which he says help with fullness and keeping muscle while losing weight.
Rona gets up to $100 million upfront and in near-term milestones, with up to $1.06 billion more possible as the program advances.
She ties the trend to more women over 40 trying to conceive, and says many are already on peptides at their first visit to her practice.
Loading…